candesartan has been researched along with quinapril in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fujita, T; Goto, A; Onozato, ML; Tojo, A; Wilcox, CS | 1 |
| Aizawa, Y; Hasegawa, G; Inoue, M; Juan, W; Kodama, M; Ma, M; Naito, M; Nakazawa, M; Narasimman, G; Saito, Y; Tachikawa, H; Takahashi, T; Tanabe, N; Wahed, MI; Watanabe, K; Yamaguchi, K; Yamamoto, T | 1 |
| Arima, T; Kamimura, R; Mifune, H; Miyahara, K; Nakamura, K; Sata, N; Suzuki, S; Tanaka, Y | 1 |
| Dalbeth, N; Hall, FC | 1 |
| Frohlich, ED; Susic, D; Varagic, J | 1 |
1 review(s) available for candesartan and quinapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for candesartan and quinapril
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Nephropathies; Female; Hydrogen Peroxide; Isoquinolines; Kidney; Lipid Peroxidation; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Proteinuria; Quinapril; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Superoxides; Tetrahydroisoquinolines; Tetrazoles; Tyrosine | 2002 |
Comparative effects of angiotensin II receptor blockade (candesartan) with angiotensin-converting enzyme inhibitor (quinapril) in rats with dilated cardiomyopathy.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Cardiomyopathy, Dilated; Isoquinolines; Male; Quinapril; Rats; Rats, Inbred Lew; Receptors, Angiotensin; Tetrahydroisoquinolines; Tetrazoles | 2003 |
Effectiveness of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker on atrial natriuretic peptide.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Heart; Male; Nitroarginine; Organ Size; Quinapril; Rats; Rats, Wistar; RNA, Messenger; Systole; Tetrahydroisoquinolines; Tetrazoles; Transcription, Genetic | 2003 |
Angiotensin receptor blockers ameliorate collagen-induced arthritis in mice: comment on the article by Sagawa et al.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arthritis, Experimental; Benzimidazoles; Biphenyl Compounds; Cell Proliferation; Collagen Type II; Disease Models, Animal; Imidazoles; Joints; Male; Mice; Mice, Inbred DBA; Olmesartan Medoxomil; Ovalbumin; Quinapril; T-Lymphocytes; Tetrahydroisoquinolines; Tetrazoles | 2005 |
Cardiovascular effects of inhibition of renin-angiotensin-aldosterone system components in hypertensive rats given salt excess.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomyopathies; Cardiovascular System; Eplerenone; Hypertension; Hypertrophy; Kidney; Male; Mineralocorticoid Receptor Antagonists; Quinapril; Rats; Rats, Inbred SHR; Receptors, Mineralocorticoid; Regional Blood Flow; Renin-Angiotensin System; Sodium Chloride, Dietary; Spironolactone; Tetrahydroisoquinolines; Tetrazoles; Ventricular Dysfunction, Left | 2010 |